Replies to post #3101 on Generex Biotechnology Corp. (fka GNBTQ)

[spaceblob]

How about this for Fair Value?

"I think this research is worth half-a-billion minimum."

"It could be argued that even this number ($500 million) represents a hugely discounted price (after all, it is 83% less than the $2.8 billion Pfizer spent). The insulin market has not gone away. Generex's current market cap of $23.44 million is absurdly, ridiculously low."


http://seekingalpha.com/article/1145681-generex-research-for-sale-on-the-cheap?source=yahoo